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Background: Fragmentation within health care systems may negatively impact the quality of chronic disease
patient care. We sought to evaluate the relationship between care management processes (CMP), integration of
services, and blood pressure (BP) control among diabetic patients.
Methods: Retrospective chart reviews were performed for a random sample of adult diabetic hypertensive patients
(n = 2,162) from 28 physician organizations in the United States (US). A modified version of the Physician Practice
Connection Readiness Survey (PPC-RS) was completed by the chief medical officer at each site. The PPC-RS
measured health system organization, delivery system redesign, decision support, clinical information systems, and
self-management support, and an integration scale measured structure, functions, and financial risk. Correlations
between PPC and integration scores and BP outcomes were assessed using Spearman correlation coefficients.
Results: Approximately 39.9% of diabetic patients had controlled BP. Mean total PPC score across sites was 55, with
highest mean scores for health system organization (81), followed by design support (60), clinical information
systems (57), self-management support (39), and delivery system redesign (39). Mean integration score was 46
(SD 27, range 4–93), and means of subscores were 64 for structure, 33 for financial risk, and 42 for function. Clinical
information systems subscore was correlated with uncontrolled BP (r = −0.38, p < 0.05), while association with total
PPC score was strong but not significant at p < 0.05 (r = −0.32). Total integration score and the structure subscore
were significantly correlated with BP control (r = 0.38, p < 0.05, and r = 0.49, p < 0.01).
Conclusions: This study suggests that CMP and service integration may be associated with better outcomes in
diabetes, though results were mixed and limited by a small number of participating sites. Primary care
implementation of integrated electronic medical records may have a beneficial effect on patient outcomes for
diabetes and other chronic diseases.Background
Fragmentation within health care systems has been
hypothesized to be a contributing factor to both subopti-
mal quality and the high cost associated with the current
state of healthcare in the US [1]. The integration of
services in physician organizations has been defined as
the ability to coordinate functions and activities (inclu-
sive of insurance coverage, payment approaches, and care
delivery systems) across separate operating units [2]. This
may include vertical integration, such as owning or
contracting for physician services, hospital services,* Correspondence: jen@medmentis.com
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and/or horizontal integration via the creation of multi-
hospital systems [2]. Within specific healthcare practices,
structured processes of patient care, in addition to the
sum total of all systems involved in the management and
delivery of patient healthcare, are referred to as care
management processes (CMP) [3]. The use of CMPs
among large physician organizations has increased sig-
nificantly in recent years [4]. The chronic care model
(CCM) is a conceptual framework used to organize
and characterize these components of comprehensive
care for chronic illnesses, which consists of six
domains: health system organizations, delivery system
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and linkages [5,6]. The National Committee for Quality
Assurance (NCQA) has developed a survey tool, Phys-
ician Practice Connections (PPC), as a basis for evaluat-
ing the use of these systems in office practices. A paper
version of the PPC, Physician Practice Connection and
Readiness Survey (PPC-RS), was adapted to assess the
presence of practice systems in the CCM. The PPC-RS is
widely used for research purposes, and has been
reliability-tested using in-practice audits and has found
to be reasonably accurate for research purposes, with a
positive predictive value ranging from 55-100% when
completed by a group’s medical director [7].
Research conducted by Solberg and colleagues in 2005
used the PPC-RS at 40 practices in Minnesota to demon-
strate a relationship between CMPs and diabetic patient
outcomes, using a PPC questionnaire targeted at diabetic
patient care [8]. While Solberg found a correlation be-
tween PPC and most measured outcomes, including gly-
cemic and lipid control, there was no correlation
between PPC and BP control. However, there was some
effect of CMP on hypertension management in Solberg’s
study, as the total PPC-RS score and domain scores for
both clinical information systems and decision support
were significantly correlated with yearly documented BP
measurements (p < 0.05, all comparisons). Since Solberg’s
study had limited generalizability based on geographic
representation, and a relationship was found between
hypertension management (though not BP control) and
use of CMP, we sought to evaluate hypertension man-
agement among diabetic patients using a more geo-
graphically diverse sample of primary care practices.
Importantly, Solberg’s 2005 study did not include a
measure of service integration, and to our knowledge the
relationship between service integration and BP control
among diabetic hypertensive patients has not been previ-
ously studied. Prior studies have found correlations be-
tween the degree of integration of services and PPC-RS
scores [9], PPC scores and clinical outcomes in depres-
sion [10], and PPC-RS scores and healthcare costs [11].
Conducted prior to the development of the CMP,
the Assessment of Chronic Illness Care (ACIC) used a
framework similar to the PPC, and early studies using
the ACIC demonstrated a relationship between some
ACIC subscores and quality of diabetes care [12,13]. A
recent cross-sectional analysis among 108 California
physician organizations found that greater use of
CMPs, as measured via a CMP index based on the
CCM by Wagner [5,6], was significantly associated
with clinical performance [14]. CMP was related to
better diabetes management and improved intermedi-
ate outcomes, which incorporated outcomes for coron-
ary artery disease and diabetes, and processes of care
(which included clinical measures such as preventivescreenings, immunizations, and asthma maintenance).
Amundson and colleagues [15] used data reported by
the Minnesota Community Measurement (MNCM) to
examine clinical outcomes among diabetic patients,
and found a significant effect of health insurance prod-
uct, plan, and physician group on all clinical endpoints
evaluated, including glycemic and BP control. Hunt
and colleagues [16] evaluated the impact of physician-
driven initiatives (including CMPs) for diabetes in
Oregon, and demonstrated subsequent improvements
in LDL-C and HbA1c testing frequency, increased use
of antidiabetic medications, and improved proportions
of patients who reached target levels for HbA1C, LDL-
cholesterol, and BP. In addition, several studies have
used alternate surveys and/or data sources to demon-
strate a relationship between quality of care in diabetes
and healthcare organizational systems. [15,17]
Fewer studies evaluating the impact of the integra-
tion of services have been reported in the literature.
Solberg et al. [9] conducted a cross-sectional survey of
97 directors from large medical groups geographically
distributed across the US and found that the overall
mean PPC-RS score was 58.5% (range = 16-98), with
highest scores for health systems. Integration subscores
were 53% for function, 30% for structure, and 29% for
finance, though a mean overall integration score was
not provided. Total PPC-RS score correlated with each
integration domain, with the strongest correlation to
functional integration. However, this study did not cor-
relate either PPC-RS or integration of services to pa-
tient clinical outcomes or quality of care measures.
Since prior research had limited generalizability
[8,15,16], but suggested a relationship between hyper-
tension care and CMP [8], the authors sought to fur-
ther evaluate hypertension management and CMP by
using a geographically diverse sample of primary care
practices in the US. Furthermore, since prior research
did not include a measure of service integration, we
sought to evaluate the relationship between diabetic
hypertension management and service integration.
Thus, the objective of our study was to examine the im-
pact of both care management processes and integration
of services on blood pressure control among diabetic
hypertensive patients who received care at participating
physician organizations.
Methods
Our cross-sectional study was conducted at 28 physician
organizations across the US. A convenience sample of
participating sites was identified by field-based outcomes
researchers employed by the study sponsor, based on site
interest in study participation and size (at least 20 pri-
mary care physicians). Participation was independent of
the site’s participation in any other research¸ process, or
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300 adult hypertensive patients aged 18 years and older
was identified by site investigators using random-
number generated patient lists. Study subjects were
required to have a diagnosis of hypertension (ICD-9-CM
401.x, 402.xx, 403.xx, 404.x, or 405.xx; or written diag-
nosis of hypertension in doctor’s notes) during the pre-
ceding year. Overall diabetes and obesity prevalence
were calculated and are presented for all hypertensive
patients identified in the original study of all hyperten-
sive patients published previously [18]. For inclusion in
this study, patients were also required to have a diagno-
sis of diabetes during the previous year, which was iden-
tified via ICD-9 codes (250.x) or clinical documentation
in the patient’s medical record. All study patients thus
had co-morbid diagnoses of hypertension and diabetes.
Subjects were required to have at least one year history
of care with the participating practice, and to have at
least 1 office visit during the year preceding the date of
data collection. Patients were excluded for pregnancy or
participation in a hypertension clinical trial during the
preceding year.
Patient demographic and clinical characteristics were
assessed via retrospective chart reviews conducted by
investigators at each participating site. Data was collected
between February 2009 and April 2010; each site collected
data for the 1-year period preceding that site’s enrollment
date. Collected patient-level data elements included the
following: patient age, gender, race/ethnicity, weight,
height, smoking status, cardiovascular-related co-morbid
conditions (including dyslipidemia and heart failure), two
BP measurements (measures from the 2 most recent
visits), prescribed antihypertensive medications, and total
number of prescribed chronic prescriptions (including
hypertension medications). BP control among diabetic
patients was defined as systolic BP (SBP) <130 and diastolic
BP (DBP) <80 [19,20]. In addition, BP was considered to
be uncontrolled if it was higher than goal BP by at least
10 mmHg SBP or 5 mmHg DBP.
Site-specific care management processes were assessed
using a modified version of the PPC-RS, which was
administered to the chief medical officer (or equivalent) at
each practice site. The version of the PPC-RS employed in
our study measured the following five domains in CCM:
health system organization (3 questions), delivery system
redesign (8 questions), decision support (9 questions),
clinical information systems (10 questions), and self-
management support (23 questions) (Figure 1). The
PPC-RS was scored by coding each item as present or
not present. The score of each domain was calculated as
a percentage, using the number of items present as the
numerator and the total possible number of items as
the denominator. The total PPC score was calculated as
the mean of the 5 domain scores, with scores rangingfrom of 0 to 100, with a higher score indicating more use
of CMP. The PPC-RS also included an integration scale
that measured structure, functions, and financial risk
(Figure 2). Total integration score was calculated as the
mean of these 3 domains, with possible scores of 0 to 100
(a higher score indicates better service integration).
This study was approved and monitored by the New
England Institutional Review Board (IORG0000444).
Statistical Analysis
Continuous variables were reported using means and
standard deviations, and categorical variables were
summarized using frequencies and percentages. PPC score
was reported overall and by organizational characteristics.
Bivariate correlations between PPC-RS survey scores and
aggregated BP outcomes at the organizational level were
assessed using Spearman correlation coefficients. The ef-
fect of independent variables on BP control was explored
by BP control quartiles; aggregated BP outcomes were
compared between the lowest (n = 7) and highest (n = 7)
quartiles of PPC score. To account for clustering of site-
specific variables, generalized linear mixed models
(Glimmix) were used to assess the effect of integration
score quartile on BP control.
Results
Description of sites
Approximately 39% of sites were located in the Midwestern
US, while 25% were located in both the Southern and
Western regions, and 11% in the Northeast. Most sites
(71%) indicated that they had electronic health record
(EHR) systems that handle all functions, while 14%
indicated that they had EHR systems with separate
ordering systems (for lab, radiology, and/or prescriptions).
Half of participating sites were physician-owned, while
39% were hospital-owned; 62% had 10 or fewer locations,
while 15% had 11–20 locations, and 23% had >20
locations. Approximately 46% of sites employed 50 or
more primary care physicians, and 34% had 20–49 pri-
mary care physicians. Mean total PPC-RS score across
all 28 participating sites was 55% (SD 19) (Table 1). The
highest PPC-RS subscore was for health system
organization (mean = 81%, SD = 29%), followed by design
support (mean = 60%, SD = 29%), clinical information
systems (mean = 57%, SD = 16%), delivery system redesign
(mean = 39%, SD = 25%), and self-management support
(mean = 39%, SD = 26%). The mean overall integration
score was 46% (SD = 27%), with mean scores of 64%
(SD = 31%) for structure, 42% (SD = 28%) for function,
and 33% (SD = 43%) for financial risk.
Patient characteristics
The entire hypertensive patient population included
8,400 patients, and 2,162 (25.7%) had concomitant
NCQA Physician Practice Connection and Readiness Survey (PPC-RS).
Figure 1 A modified version of the PPC-RS was administered to the chief medical officer (or equivalent) at each practice site to
characterize site-specific care management processes. The version of the PPC-RS employed in our study measured five out of the six
domains in the chronic care model (CCM). Adapted from the
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among hypertensive patients ranged from 11.7%-42.0%.
Among the diabetic hypertensive patient population
included in this study, mean patient age was 65.4 (SD
12.5) years and 51.2% were female; 39.9% (SD 11.8) had
controlled BP, and 30.7% (SD 8.8) had uncontrolled
BP. Patient demographic and clinical characteristics
are included in Table 2. Both obesity and diabetes
prevalence were slightly higher among men as
compared to women. While obesity prevalence was similar
for Caucasian (44.9%) and African-American (45.1%)patients, the prevalence of diabetes was higher among
African-Americans (36.0%) than Caucasians (26.6%), and
diabetic African-American patients were more likely to
have uncontrolled BP (47.1%) than Caucasians (32.9%).
Non-obese patients were more likely to have BP con-
trolled as compared to obese patients (44.7% vs 36.6%).
Obesity (38.6%) and diabetes (22.0%) prevalence were
lower in the Western US as compared to other geo-
graphic regions. Although obesity prevalence was com-
parable for the Southern, Northeastern, and Midwestern
geographic regions, practices located in the Southern US
from Solberg et al. 2009 [9].
Figure 2 The PPC-RS included an integration scale that measured structure, functions, and financial risk. Total integration score was
calculated as the mean of these 3 domains, with possible scores of 0 to 100, with a higher score indicating better service integration. Adapted
Table 1 Physician practice connections score and integration of services score for all 28 sites
Mean Standard deviation Minimum Lower quartile Median Upper quartile Maximum
Physician Practice Connections Score 55 19 24 38 52 68 94
Health System Organization 81 29 0 67 100 100 100
Delivery System Redesign 39 25 0 25 38 50 100
Clinical Information Systems 57 16 22 44 57 67 89
Design Support 60 29 13 38 56 88 100
Self-Management Support 39 26 8 17 33 63 100
Integration Score 46 27 4 25 48 66 93
Structure 64 31 11 39 61 100 100
Financial Risk 33 43 0 0 0 80 100
Function 42 28 0 20 40 70 80
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Table 2 Demographic and clinical factors affecting diabetes and obesity prevalence and BP control among diabetic
hypertensive patients from 28 participating practices
Mean (SD) obesity prevalence
among all study patients
(n = 8,400)
Mean (SD) DM prevalence
among all study patients
(n = 8,400)
Mean (SD) % with BP control1
among diabetic study patients
(n = 2,162)
Mean (SD) % with BP uncontrolled2
among diabetic study patients
(n = 2,162)
Gender
Male 45.5% (8.5%) 27.4% (7.9%) 39.9% (13.9%) 31.8% (10.6%)
Female 43.0% (8.8%) 24.5% (7.6%) 40.1% (12.6%) 29.3% (10.4%)
Age
<65 53.5% (8.3%) 23.7% (7.7%) 37.5% (14.6%) 31.8% (12.7%)
> = 65 34.4% (8.4%) 28.3% (7.7%) 41.9% (13.3%) 29.9% (9.0%)
Race/ethnicity
Caucasian 44.9% (7.8%) 26.6% (7.6%) 36.9% (12.8%) 32.9% (7.9%)
African American 45.1% (22.7%) 36.0% (23.2%) 33.5% (25.5%) 47.1% (31.1%)
Hispanic 38.6% (24.5%) 25.4% (28.7%) 42.7% (42.2%) 48.8% (40.2%)
Other/Missing 37.9% (15.9%) 26.1% (19.4%) 42.8% (21.9%) 25.7% (19.1%)
BMI
<30 18.0% (8.5%) 44.7% (19.2%) 30.9% (15.9%)
> = 30 33.0% (8.4%) 36.6% (12.1%) 32% (9.2%)
Region
Northeast 45.7% (2.4%) 23.3% (5.2%) 37.7% (13.8%) 26.6% (9.2%)
Midwest 47.5% (8.8%) 25.5% (5.5%) 41.5% (12.6%) 27.9% (7.1%)
South 44.0% (9.2%) 30.9% (8.6%) 34.2% (6.6%) 38.0% (7.7%)
West 38.6% (5.1%) 22.0% (6.7%) 44.1% (13.7%) 29.7% (9.6%)
1Controlled BP defined as BP <130/80 mmHg.
2Uncontrolled BP defined as SBP > =140 mmHg and/or DBP > =85 mmHg.
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US also had the lowest proportion of patients with BP con-
trolled (34.2%) and the highest proportion with BP
exceeding goal by either >10mmHg SBP or >5mm DBP
(38.0%).
Selected patient characteristics, stratified by total PPC
score and total integration score quartiles, are presented
in Figure 3. Overall, a majority of patients were
prescribed 2 or more antihypertensive medications
(67.9%). Practices ranked in the highest quartile for both
PPC score and total integration score had the lowest
smoking prevalence. Mean change in BP between the 2
most recent measurements was −1.3/-0.5 mmHg, and
was not related to PPC quartile.
PPC and integration score results
The relationship between PPC-RS score quartiles and
BP control is depicted in Table 3. Sites ranked in the
highest quartile of total integration score had better BP
control (41.4%) than those in the lowest quartile (32.7%).
Compared to the lowest quartile, the 2nd, 3rd, and 4th
quartiles had somewhat higher adjusted probability of
BP control (p = 0.16, 0.08, and 0.11, respectively). Sites
in the highest quartile of total PPC score had somewhatbetter BP control than those in the lowest quartile
(42.2% vs 37.0%, p = NS). This trend towards better BP
control was also observed when comparing the 1st and
4th quartiles for the domain scores for health services
organization, delivery system redesign, and clinical infor-
mation systems. A trend towards better control was also
observed for the service integration domain scores of
structure, function, and, to a lesser extent, financial risk.
Correlation values between total PPC score, total inte-
gration score, and associated domain scores are also
depicted in Table 3. While total PPC score was not sig-
nificantly correlated with BP control (r = 0.13, p = 0.52),
the correlation for total PPC score and uncontrolled BP
was strong but not statistically significant (r = −0.32,
p = 0.10). A significant correlation was observed for
the clinical information systems domain score and
uncontrolled BP (r = −0.38, p = 0.04). The correlation
value for the overall service integration score and
controlled BP was 0.38 (p < 0.05). The integration do-
main score of structure was significantly correlated
with controlled BP (r = 0.49, p < 0.01).
Multivariate analyses using general linear mixed mod-
eling indicated a strong correlation between controlled
BP and integration for those practices in the highest
Figure 3 The relationship between total Physician Practice Connection Readiness Survey (PPC-RS) and Integration of Services (IOS)
score quartiles and patient BP control, antihypertensive medication regimen, and obesity and smoking status are presented.
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information systems domain score of the PPC-RS was
associated with controlled BP, though this also did not
reach statistical significance at p < 0.05 (r = 0.36, p = 0.095).
Discussion
Our cross-sectional study, which employed a modified
PPC-RS, found a mean total PPC score of 55% across all
sites. However, a considerable amount of variation
among practices was observed, as the range of scores
was 24%-94%. Highest mean scores were observed for
health system organization and design support domain
subscores, and lowest subscores were observed for self-
management support and delivery system redesign.
Overall mean integration score was 46, with highest
subscores for structure and lowest for financial risk. In-
tegration of services was more strongly correlated with
BP control in our diabetic hypertensive population than
the presence of care management processes. A signifi-
cant correlation between uncontrolled BP and the clin-
ical information systems subscore was observed. A trend
was observed between survey scores and BP outcomes,
as sites in the highest quartile of total PPC score andtotal integration score had better BP control than
those in the lowest quartile. These findings may not
be suitably reflected by statistical comparisons, as
our relatively small number of investigative sites
resulted in large standard deviations which made for-
mal statistical testing somewhat challenging. These
findings are consistent with those observed in a lar-
ger hypertensive study cohort (diabetic and non-
diabetic patients) using the same 28 study sites that
was published previously [18]. That study, however,
identified which specific practices were associated
with BP control, with results suggesting that the use
of physician education regarding patient medication
compliance, the use of systematic processes for hyperten-
sion screening, and the maintenance of hypertensive pa-
tient lists with clinical characteristics were all associated
with improved BP control.
BP control was estimated using a cross-sectional
retrospective chart review of a sample of diabetic
hypertensive patients from practices across the US.
We found that 39.9% of our population had BP con-
trolled to <130/80 mmHg, the target measurement
recommended by current treatment guidelines [19,20].
Table 3 Relationship between process survey scores, obesity and diabetes prevalence, and BP control among diabetic
hypertensive patients
N (# practices) BP control among diabetic
study patients
Correlation of score and BP
control (<130/80 mmHg)
among DM patients
Correlation of score and BP
non-control (BP ≥140/85 mmHg)
among DM patients
Mean SD
Total PPC Score 0.13 −0.32 (p = 0.10)
1st quartile 7 37.0% 10.3%
4th quartile 7 42.2% 11.3%
Health System Organization 0.28 −0.18
1st quartile 10 35.9% 9.3%
2nd quartile 18 42.1% 12.7%
Delivery System Redesign 0.18 −0.14
1st quartile 12 37.7% 10.8%
4th quartile 6 41.4% 7.8%
Clinical Info Systems 0.21 −0.38 (p = 0.04)
1st quartile 9 35.2% 5.8%
4th quartile 4 46.1% 13.2%
Design Support −0.09 −0.30
1st quartile 9 41.3% 9.3%
4th quartile 4 34.7% 6.8%
Self-management support 0.04 −0.29
1st quartile 9 36.2% 8.1%
4th quartile 7 33.8% 8.1%
Total service integration score 0.38 (p = 0.05) −0.19
1st quartile 7 32.7% 10.8%
4th quartile 7 41.4% 8.8%
Integration- Structure 0.49 (p = 0.01) −0.30
1st quartile 7 33.8% 10.1%
4th quartile 14 44.5% 11.4%
Integration- Financial risk 0.24 −0.15
1st quartile 16 38.0% 13.2%
4th quartile 6 40.9% 5.9%
Integration-Function 0.24 −0.06
1st quartile 10 40.5% 12.4%
4th quartile 4 48.1% 10.0%
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persons is fairly consistent with US normative data, as
the most current data from the National Health and
Nutrition Examination Survey estimate that across the
US, 37.5% of diabetic persons have BP controlled to
this level [21]. Variation in diabetes prevalence among
investigative sites was evident (11.7%-42.0%); a partial
explanation for this wide range in prevalence is geo-
graphical and racial/ethnic variation represented by
sites. Sites located in the South tended to have more
diabetic patients represented in the study, and prevalence
was considerably higher among African-Americans.Previous work to evaluate a potential relationship be-
tween care management practices and diabetic patient
outcomes has been published by Solberg and colleagues
[8] and Amundson et al. [15]. Solberg used the PPC-RS
at 40 practices in Minnesota in 2005 to evaluate the rela-
tionship between CMP and clinical outcomes in diabetes
[8]. Mean total PPC-RS in Solberg’s study was 67.3
(range 32.2-95.8) and thus is somewhat higher than the
mean of 55 we observed in the current study; however,
the mean PPC-RS for our study’s Midwestern sites was
62.2%, which is similar to the mean PPC-RS observed by
Solberg. Among the 40 Minnesota practices studied by
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mean BP control (<130/85 mmHg) was 49%; in our
study, mean BP control, defined as <130/80 mmHg was
40%, and it is likely that the discrepancy in BP control
definitions between our study and Solberg’s are largely
responsible for the disparate BP control estimates. In
Solberg’s study, most process and outcome measures
were significantly correlated, including glycemic control
and LDL-cholesterol. Nevertheless, BP control was not
correlated to PPC scores, and a quartile analysis similar
to the one conducted in our study did not reveal a trend
towards improved BP control and PPC scores. However,
in Solberg’s study, the total PPC-RS score and the
subscores for clinical information systems and decision
support were all significantly correlated with yearly
documented BP measurements. Solberg had also used a
modified PPC tool to evaluate the relationship between
CMPs and outcomes in depression management among
Minnesota medical groups. Mean overall PPC scores in
this study were 54%, and findings supported a relation-
ship between better quality of care among depressive
patients and overall PPC score, as well as for the
subscores associated with decision support and delivery
system redesign. Our study, by contrast, included 28 pri-
mary care practices located throughout the US, and
therefore our results may be more generalizeable to the
US diabetic hypertensive population that those of
Solberg and colleagues. Furthermore, we included an in-
tegration of services component to our PPC-RS and
found a correlation between BP control and service inte-
gration; an integration of services component was not
included as part of Solberg’s study.
While our study provides useful information related to
service integration and care management process in pri-
mary care settings, several caveats are important to con-
sider. Even though our study included data on 2,162
diabetic hypertensive patients at 28 US primary care
practices, our study may have benefitted from the inclu-
sion of more physician practices to increase the effective
sample size and associated power for statistical
comparisons for analysis of BP outcomes and PPC-RS
scores. Our study was cross-sectional, and thus the BP
measurements recorded were not longitudinal and may
not adequately reflect patient BP control over time. Fu-
ture studies may consider longitudinally following
newly-diagnosed patients to more adequately assess pa-
tient BP management over time. Site selection was non-
random and was based on several factors, including site
interest in participation, and the study was not designed
to be representative of the demographic composition of
the US diabetic hypertensive population as a whole.
Thus, it is difficult to ascertain whether selection bias
may play a role in some of our study’s findings. We did
not collect information on glycemic control, thus wewere unable to evaluate this as an endpoint in our dia-
betic study population. Some additional patient informa-
tion was not available for analysis, including duration of
hypertension or diabetes, patient compliance with
prescribed antihypertensive and antidiabetic medication
regimen, duration of medication use, and patient insur-
ance status. Furthermore, since the PPC-RS was
completed by the chief medical officer at each site, site
characteristics may, in a sense, be regarded as self-
reported data, and this should be considered in the in-
terpretation of our findings. Nevertheless, despite these
limitations, this study provides important information
supporting a positive impact of care management
processes and service integration in primary care
practices’ management of chronic diseases.
Conclusions
Though our findings were mixed and are limited by a small
number of participating practices, our study suggests that
the integration of services and the use of care management
processes, and clinical information systems in particular,
may lead to improved outcomes in diabetic hypertensive
persons. Our findings add to the current literature
regarding CMP and outcomes in diabetes, as our results
may be more generalizeable to primary care across the US
diabetic hypertensive population than previously published
studies. Furthermore, to our knowledge, ours is the first
study to suggest a relationship between service integration
and outcomes among diabetic hypertensive persons. Our
results suggesting a link between the clinical information
systems domain score and improved BP control are par-
ticularly important and timely as an increasing number of
primary care practices move towards integrated electronic
medical records.
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